Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value: $142M (100.0% shares, 0.0% debt)

Holdings (54)

— SPDR S&P 500 ETF TR 10.4%
Value $14.68M Shares 75,000 Share Price $195.72 Est. Cost/Share — Unrealized @ Report Date —
— MYLAN INC 5.5%
Value $7.734M Shares 150,000 Share Price $51.56 Est. Cost/Share — Unrealized @ Report Date —
— ACTAVIS PLC 4.7%
Value $6.692M Shares 30,000 Share Price $223.07 Est. Cost/Share $223.07 Unrealized @ Report Date —
— MEDIVATION INC 4.3%
Value $6.166M Shares 80,000 Share Price $77.08 Est. Cost/Share $77.08 Unrealized @ Report Date —
— COOPER COS INC 3.8%
Value $5.421M Shares 40,000 Share Price $135.53 Est. Cost/Share $135.53 Unrealized @ Report Date —
TEVA TEVA PHARMACEUTICAL INDS LTD 3.7%
Value $5.242M Shares 100,000 Share Price $52.42 Est. Cost/Share $52.42 Unrealized @ Report Date —
BSX BOSTON SCIENTIFIC CORP 3.6%
Value $5.108M Shares 400,000 Share Price $12.77 Est. Cost/Share $13.00 Unrealized @ Report Date 0.0%
— MEDTRONIC INC 3.4%
Value $4.782M Shares 75,000 Share Price $63.76 Est. Cost/Share $63.76 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 3.3%
Value $4.738M Shares 75,000 Share Price $63.17 * Est. Cost/Share $59.44 Unrealized @ Report Date 0.0%
CYH COMMUNITY HEALTH SYS INC NEW 3.2%
Value $4.537M Shares 100,000 Share Price $45.37 * Est. Cost/Share $34.00 Unrealized @ Report Date -2.2%
ATRC ATRICURE INC 2.9%
Value $4.136M Shares 225,000 Share Price $18.38 * Est. Cost/Share $18.10 Unrealized @ Report Date -8.0%
INSM INSMED INC 2.8%
Value $3.996M Shares 200,000 Share Price $19.98 * Est. Cost/Share $15.15 Unrealized @ Report Date -2.3%
— BIODELIVERY SCIENCES INTL IN 2.6%
Value $3.621M Shares 300,000 Share Price $12.07 Est. Cost/Share — Unrealized @ Report Date —
— SPECTRANETICS CORP 2.3%
Value $3.263M Shares 142,600 Share Price $22.88 Est. Cost/Share $23.62 Unrealized @ Report Date —
BRKR BRUKER CORP 2.2%
Value $3.155M Shares 130,000 Share Price $24.27 * Est. Cost/Share $19.45 Unrealized @ Report Date +7.2%
— SYNAGEVA BIOPHARMA CORP 2.2%
Value $3.144M Shares 30,000 Share Price $104.80 Est. Cost/Share $104.80 Unrealized @ Report Date —
— TORNIER N V 2.0%
Value $2.806M Shares 120,000 Share Price $23.38 Est. Cost/Share $19.35 Unrealized @ Report Date —
— COVIDIEN PLC 1.9%
Value $2.705M Shares 30,000 Share Price $90.17 Est. Cost/Share $90.17 Unrealized @ Report Date —
— ANACOR PHARMACEUTICALS INC 1.9%
Value $2.66M Shares 150,000 Share Price $17.73 Est. Cost/Share $18.04 Unrealized @ Report Date —
HCA HCA HOLDINGS INC 1.8%
Value $2.537M Shares 45,000 Share Price $56.38 * Est. Cost/Share $49.04 Unrealized @ Report Date 0.0%
— INTERCEPT PHARMACEUTICALS IN 1.7%
Value $2.366M Shares 10,000 Share Price $236.60 Est. Cost/Share $311.12 Unrealized @ Report Date —
— PROSENSA HLDG N V 1.6%
Value $2.209M Shares 175,000 Share Price $12.62 Est. Cost/Share $12.62 Unrealized @ Report Date —
ARAY ACCURAY INC 1.6%
Value $2.2M Shares 250,000 Share Price $8.80 Est. Cost/Share $7.76 Unrealized @ Report Date +11.6%
ENTA ENANTA PHARMACEUTICALS INC 1.5%
Value $2.154M Shares 50,000 Share Price $43.08 * Est. Cost/Share $36.87 Unrealized @ Report Date +3.5%
— GW PHARMACEUTICALS PLC 1.5%
Value $2.146M Shares 20,000 Share Price $107.30 Est. Cost/Share $59.36 Unrealized @ Report Date —
REGN REGENERON PHARMACEUTICALS 1.5%
Value $2.119M Shares 7,500 Share Price $282.53 * Est. Cost/Share $294.74 Unrealized @ Report Date 0.0%
— AMAG PHARMACEUTICALS INC 1.5%
Value $2.072M Shares 100,000 Share Price $20.72 Est. Cost/Share $19.35 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 1.4%
Value $2.004M Shares 600,000 Share Price $3.34 * Est. Cost/Share $2.35 Unrealized @ Report Date 0.0%
SNN SMITH & NEPHEW PLC 1.3%
Value $1.786M Shares 20,000 Share Price $89.30 Est. Cost/Share $89.30 Unrealized @ Report Date —
EW EDWARDS LIFESCIENCES CORP 1.2%
Value $1.717M Shares 20,000 Share Price $85.85 * Est. Cost/Share $11.54 Unrealized @ Report Date +17.5%
— DEPOMED INC 1.2%
Value $1.668M Shares 120,000 Share Price $13.90 Est. Cost/Share $12.77 Unrealized @ Report Date —
— DEPOMED INC 1.2%
Value $1.668M Shares 120,000 Share Price $13.90 Est. Cost/Share — Unrealized @ Report Date —
— NPS PHARMACEUTICALS INC 1.2%
Value $1.653M Shares 50,000 Share Price $33.06 Est. Cost/Share — Unrealized @ Report Date —
— OREXIGEN THERAPEUTICS INC 1.1%
Value $1.545M Shares 250,000 Share Price $6.18 Est. Cost/Share $6.18 Unrealized @ Report Date —
— RECEPTOS INC 1.1%
Value $1.491M Shares 35,000 Share Price $42.60 Est. Cost/Share $42.60 Unrealized @ Report Date —
— NPS PHARMACEUTICALS INC 0.9%
Value $1.322M Shares 40,000 Share Price $33.05 Est. Cost/Share $33.05 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS IN 0.8%
Value $1.136M Shares 150,000 Share Price $7.57 Est. Cost/Share — Unrealized @ Report Date —
— FLAMEL TECHNOLOGIES SA 0.8%
Value $1.125M Shares 75,000 Share Price $15.00 Est. Cost/Share $11.26 Unrealized @ Report Date —
CPRX CATALYST PHARM PARTNERS INC 0.8%
Value $1.106M Shares 437,296 Share Price $2.53 * Est. Cost/Share $2.09 Unrealized @ Report Date +2.3%
— THERAPEUTICSMD INC 0.8%
Value $1.105M Shares 250,000 Share Price $4.42 Est. Cost/Share $5.93 Unrealized @ Report Date —
— INOVIO PHARMACEUTICALS INC 0.8%
Value $1.081M Shares 100,000 Share Price $10.81 Est. Cost/Share — Unrealized @ Report Date —
— CYNOSURE INC 0.7%
Value $1.063M Shares 50,000 Share Price $21.26 Est. Cost/Share $21.26 Unrealized @ Report Date —
— NANOSTRING TECHNOLOGIES INC 0.7%
Value $1.047M Shares 70,000 Share Price $14.96 Est. Cost/Share $20.65 Unrealized @ Report Date —
— AIR METHODS CORP 0.7%
Value $1.033M Shares 20,000 Share Price $51.65 Est. Cost/Share $51.65 Unrealized @ Report Date —
INFIQ INFINITY PHARMACEUTICALS INC 0.7%
Value $956K Shares 75,000 Share Price $12.75 * Est. Cost/Share $10.42 Unrealized @ Report Date 0.0%
— UNILIFE CORP NEW 0.6%
Value $888K Shares 300,000 Share Price $2.96 Est. Cost/Share $4.21 Unrealized @ Report Date —
HRTX HERON THERAPEUTICS INC 0.6%
Value $862K Shares 70,000 Share Price $12.31 * Est. Cost/Share $11.95 Unrealized @ Report Date 0.0%
— OCERA THERAPEUTICS INC 0.5%
Value $764K Shares 100,000 Share Price $7.64 Est. Cost/Share $11.33 Unrealized @ Report Date —
— REVANCE THERAPEUTICS INC 0.5%
Value $680K Shares 20,000 Share Price $34.00 Est. Cost/Share $31.50 Unrealized @ Report Date —
— BIOLASE INC 0.5%
Value $660K Shares 300,000 Share Price $2.20 Est. Cost/Share $2.41 Unrealized @ Report Date —
— DYAX CORP 0.4%
Value $624K Shares 65,000 Share Price $9.60 Est. Cost/Share $7.54 Unrealized @ Report Date —
— VENTRUS BIOSCIENCES INC 0.2%
Value $262K Shares 200,000 Share Price $1.31 Est. Cost/Share $1.31 Unrealized @ Report Date —
— WRIGHT MED GROUP INC 0.1%
Value $82,000 Shares 55,150 Share Price $1.49 Est. Cost/Share $0.33 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 0.0%
Value $66,000 Shares 1,000 Share Price $66.00 * Est. Cost/Share $58.69 Unrealized @ Report Date +21.2%